322 related articles for article (PubMed ID: 17478770)
21. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Ahn EH
Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
[TBL] [Abstract][Full Text] [Related]
22. Detection of alveolar rhabdomyosarcoma in pleural fluid with immunocytochemistry on cell block and determination of PAX/FKHR fusion mRNA by reverse transcription-polymerase chain reaction.
Sawangpanich R; Larbcharoensub N; Jinawath A; Pongtippan A; Anurathapan U; Hongeng S
J Med Assoc Thai; 2011 Nov; 94(11):1394-8. PubMed ID: 22256481
[TBL] [Abstract][Full Text] [Related]
23. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
[TBL] [Abstract][Full Text] [Related]
24. Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.
Huang SC; Ghossein RA; Bishop JA; Zhang L; Chen TC; Huang HY; Antonescu CR
Am J Surg Pathol; 2016 Jan; 40(1):51-9. PubMed ID: 26371783
[TBL] [Abstract][Full Text] [Related]
25. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.
Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718
[TBL] [Abstract][Full Text] [Related]
26. Molecular biology of rhabdomyosarcoma.
Gallego Melcón S; Sánchez de Toledo Codina J
Clin Transl Oncol; 2007 Jul; 9(7):415-9. PubMed ID: 17652054
[TBL] [Abstract][Full Text] [Related]
27. Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma.
Cerveira N; Torres L; Ribeiro FR; Henrique R; Pinto A; Bizarro S; Ferreira AM; Lopes C; Teixeira MR
Cancer Genet Cytogenet; 2005 Dec; 163(2):138-43. PubMed ID: 16337856
[TBL] [Abstract][Full Text] [Related]
28. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
[TBL] [Abstract][Full Text] [Related]
29. PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization.
Dumont SN; Lazar AJ; Bridge JA; Benjamin RS; Trent JC
J Cancer Res Clin Oncol; 2012 Feb; 138(2):213-20. PubMed ID: 22089931
[TBL] [Abstract][Full Text] [Related]
30. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method.
Kelly KM; Womer RB; Barr FG
Cancer; 1996 Sep; 78(6):1320-7. PubMed ID: 8826957
[TBL] [Abstract][Full Text] [Related]
31. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma.
Tobar A; Avigad S; Zoldan M; Mor C; Goshen Y; Zaizov R
Diagn Mol Pathol; 2000 Mar; 9(1):9-13. PubMed ID: 10718207
[TBL] [Abstract][Full Text] [Related]
33. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.
Wachtel M; Dettling M; Koscielniak E; Stegmaier S; Treuner J; Simon-Klingenstein K; Bühlmann P; Niggli FK; Schäfer BW
Cancer Res; 2004 Aug; 64(16):5539-45. PubMed ID: 15313887
[TBL] [Abstract][Full Text] [Related]
34. Alveolar rhabdomyosarcoma of the paranasal sinuses in a 57-year-old woman with 1:16 translocation.
Manucha V; Castellani R; Sun CC
Int J Surg Pathol; 2006 Jul; 14(3):238-42. PubMed ID: 16959712
[TBL] [Abstract][Full Text] [Related]
35. FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma.
Bois PR; Izeradjene K; Houghton PJ; Cleveland JL; Houghton JA; Grosveld GC
J Cell Biol; 2005 Sep; 170(6):903-12. PubMed ID: 16157701
[TBL] [Abstract][Full Text] [Related]
36. [Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma].
Gao H; Ou YL; Zhang KR; Zhang ZB; Wang WL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):42-7. PubMed ID: 17285543
[TBL] [Abstract][Full Text] [Related]
37. Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group.
Barr FG; Smith LM; Lynch JC; Strzelecki D; Parham DM; Qualman SJ; Breitfeld PP
J Mol Diagn; 2006 May; 8(2):202-8. PubMed ID: 16645206
[TBL] [Abstract][Full Text] [Related]
38. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
Sublett JE; Jeon IS; Shapiro DN
Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
[TBL] [Abstract][Full Text] [Related]
39. Classification of rhabdomyosarcoma and its molecular basis.
Parham DM; Barr FG
Adv Anat Pathol; 2013 Nov; 20(6):387-97. PubMed ID: 24113309
[TBL] [Abstract][Full Text] [Related]
40. Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review.
Treetipsatit J; Kittikowit W; Zielenska M; Chaipipat M; Thorner PS; Shuangshoti S
Pediatr Dev Pathol; 2009; 12(5):383-9. PubMed ID: 19175284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
